Male Reproductive Toxicity Induced by Chronic Dinotefuran Exposure: In Vivo and In Silico Evidence and the Ameliorative Role of Rosmarinus officinalis
- PMID: 41319930
- DOI: 10.1016/j.reprotox.2025.109118
Male Reproductive Toxicity Induced by Chronic Dinotefuran Exposure: In Vivo and In Silico Evidence and the Ameliorative Role of Rosmarinus officinalis
Abstract
Dinotefuran (DINO), a chiral neonicotinoid insecticide, is widely used for pest control but increasing evidence suggests potential risks to non-target organisms, including mammals. This study evaluated the reproductive toxicity of chronic DINO exposure in male albino rats and assessed the ameliorative potential of Rosmarinus officinalis extract (RE). Male rats received DINO orally once daily at doses of 94 or 281mg/kg for 25 consecutive weeks. DINO exposure impaired reproductive performance, as shown by significant reductions in the male mating and fertility indices, decreased testicular weight, and deterioration of sperm quality (count, motility, and viability), accompanied by increased sperm aneuploidy. Endocrine disruption was evident, with altered serum hormone profiles. Histopathological analysis revealed extensive testicular damage, and immunohistochemistry confirmed increased caspase-3 expression, reflecting enhanced apoptosis. Molecular docking supported these findings by demonstrating strong binding interactions of DINO with key enzymes and receptors involved in steroidogenesis and reproductive regulation (CYP11A1, CYP17A1, 3β-HSD, 17β-HSD, CYP19A1, caspase-3, AR, ERα/β, PRLR, TRα/β, FSHR, and LHCGR). Notably, co-treatment with RE (220mg/kg) significantly alleviated these adverse effects, underscoring its antioxidant and ameliorative role. In conclusion, chronic DINO exposure poses substantial risks to male reproductive health, whereas RE demonstrates promising potential as a protective agent, particularly relevant in contexts of high pesticide exposure.
Keywords: Dinotefuran; Molecular docking; Reproductive Toxicity; Rosemary extract; Testicular damage.
Copyright © 2025. Published by Elsevier Inc.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
LinkOut - more resources
Full Text Sources
Research Materials
